Difference between revisions of "LINC02489"

From LncRNAWiki
Jump to: navigation, search
 
Line 4: Line 4:
 
LINC02489:long intergenic non-protein coding RNA 2489
 
LINC02489:long intergenic non-protein coding RNA 2489
  
CTD-2589M5<ref name="ref1" />  
+
CTD-2589M5 <ref name="ref1" />
===Characteristics===
 
  
 +
===Function===
 +
LncRNA CTD-2589M5 is found to have conserved interaction with miR-210 based on the prediction results of mircode (http://www.mircode.org/) <ref name="ref1" />.
  
===Cellular Localization===
+
===Expression===
 +
Expression level of lncRNA CTD-2589M5 is significantly increased in osteosarcoma tissues comparing with the matched non-tumor tissues <ref name="ref1" />.
  
 +
===Diseases===
 +
Osteosarcoma <ref name="ref1" />
  
===Function===
 
LncRNA CTD-2589M5 can conserved interact with miR-210.<ref name="ref1" />
 
===Regulation===
 
 
===Diseases===
 
Osteosarcoma<ref name="ref1" />
 
===Expression===
 
The expression of lncRNA CTD-2589M5 is significantly increased in osteosarcoma tissues compared to their matched non-tumor tissues .<ref name="ref1" />
 
 
===Sequence===
 
===Sequence===
 
>XR_001748205.1 PREDICTED: Homo sapiens uncharacterized LOC101928919 (LOC101928919), transcript variant X2, ncRNA
 
>XR_001748205.1 PREDICTED: Homo sapiens uncharacterized LOC101928919 (LOC101928919), transcript variant X2, ncRNA

Latest revision as of 09:13, 28 August 2017

Annotated Information

Name

LINC02489:long intergenic non-protein coding RNA 2489

CTD-2589M5 [1]

Function

LncRNA CTD-2589M5 is found to have conserved interaction with miR-210 based on the prediction results of mircode (http://www.mircode.org/) [1].

Expression

Expression level of lncRNA CTD-2589M5 is significantly increased in osteosarcoma tissues comparing with the matched non-tumor tissues [1].

Diseases

Osteosarcoma [1]

Sequence

>XR_001748205.1 PREDICTED: Homo sapiens uncharacterized LOC101928919 (LOC101928919), transcript variant X2, ncRNA

000001 AGTTAGGGGA TGGAGGCCAA CGTTGGCTCT GCAAACACCA CCTCCACAGG CCCAAATACT GCAGGTCACG AGAGGCACTG 000080
000081 ATGGCAGCTC CTTCTGTGAC GGGCTCAGGA ACACCTGGTT GCTGCTCTCC ATGAGCTGTT CCAACTGTGA AGCAAAAGCT 000160
000161 TCATGCATAA AGGCATCCCA ACGCAGTCAA TGACGCACAG GAGAAAGAGG ACAGAGATAA GCTTCTTGCC TGTTCCAGAC 000240
000241 ACTGAGGATC AGGCAGAGAG AGAGGCTCCT GCCAGGCTGA GCTTTTCCGG AGTGTGGATA TGAACAGCCG TCTTGGGTCC 000320
000321 TGAGGTGGAA GCCATGTGTG GAAGATGGAG GGCATCGGTT AGAAGGAGTC TAGTCCCTGA TGGTCACTGA GCTGCAGAAC 000400
000401 CAGCCTGGGC TGCTTCCTGC TGGATGTCAC TTACTAGAGA GCGAAATTAA ATGTGCTTCA GCTACTGTTA


Labs working on this lncRNA

  • Department of Orthopaedics, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, China.

References

  1. 1.0 1.1 1.2 1.3 Wang Z, Liu Z, Wu S. Long non-coding RNA CTA sensitizes osteosarcoma cells to doxorubicin through inhibition of autophagy. Oncotarget. 2017 May 9;8(19):31465-31477.